Innate Pharma (IPHA) Operating Margin (2021 - 2024)
Innate Pharma's (IPHA) quarterly Operating Margin came in at 317.29% in Q2 2024, down 31617.0% YoY from N/an in Q3 2023, and down 28076.78% on a QoQ basis from 1.13% in Q2 2023.
Innate Pharma (IPHA) Operating Margin (2021 - 2024) Analysis & Trends
Innate Pharma (IPHA) has 3 years of Operating Margin data on file, last reported at 317.29% in Q2 2024.
- Quarterly Operating Margin fell 31617.0% year-over-year to 317.29% in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 0.23% (down 4.0% YoY) and the FY2025 annual result came in at 599.76%, down 34343.0% from the prior year.
- Operating Margin fell to 317.29% in Q2 2024, from 1.13% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 1.13% in Q2 2023 to a low of 394.86% in Q4 2021.
- A 3-year average of 237.76% and a median of 317.29% in 2024 frame the typical range for Operating Margin.
- The widest YoY moves for Operating Margin: up 31617 bps in 2024, down 31617 bps in 2024.
- Tracing IPHA's Operating Margin over 3 years: stood at 394.86% in 2021, then jumped by 100 bps to 1.13% in 2023, then sank by 28077 bps to 317.29% in 2024.
- The last three Operating Margin figures came in at 317.29% (Q2 2024), 1.13% (Q2 2023), and 394.86% (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Innate Pharma | 202.03 Mn | 202.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -317.29% |
| Jun 30, 2023 | -1.13% |
| Dec 31, 2021 | -394.86% |